Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NOVARTIS GENE THERAPIES SWITZERLAND GMBH
NUF
Active
Org 821196922
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2018 · 7 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
NOVARTIS GENE THERAPIES SWITZERLAND GMBH
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SR
Sissel Rodahl
Contact Person
Contact Person
2018
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on NOVARTIS GENE THERAPIES SWITZERLAND GMBH
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
